1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Encorafenib plus cetuximab with or without binimetinib for BRAF V600E metastatic colorectal cancer: Updated survival results from a randomized, three-arm, phase III study versus choice of either irinotecan or FOLFIRI plus cetuximab (BEACON CRC)
    Meeting Abstract

    Kopetz, S.; Grothey, A.; Van Cutsem, E.; Yaeger, R.; Wasan, H. S.; Yoshino, T.; Desai, J.; Ciardiello, F.; Loupakis, F.; Hong, Y. S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Immediate post-thermal ablation biopsy of colorectal liver metastases to predict oncologic outcomes
    Meeting Abstract

    Vasiniotis Kamarinos, N.; Vakiani, E.; Gonen, M.; Kemeny, N. E.; Covey, A. M.; Brown, K. T.; Brody, L. A.; Deipolyi, A. R.; Camacho, J.; Boas, F. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A retrospective analysis of post second-line chemotherapy treatment outcomes for patients with advanced or metastatic cholangiocarcinoma and FGFR2 fusions
    Meeting Abstract

    Javle, M. M.; Sadeghi, S.; El-Khoueiry, A. B.; Goyal, L.; Philip, P. A.; Kelley, R. K.; Borbath, I.; Macarulla, T.; Yong, W. P.; Tanasanvimon, S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Clinicopathological and molecular biological characteristics of early-onset stage II/III colorectal adenocarcinoma: An analysis of 25 studies with 47,184 patients (pts) in the adjuvant colon cancer end points (ACCENT) database
    Meeting Abstract

    Jin, Z.; Dixon, J. G.; Parekh, H. D.; Alberts, S. R.; Yothers, G.; Allegra, C. J.; Kerr, R.; Haller, D. G.; De Gramont, A.; Yoshino, T.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial
    Meeting Abstract

    Garcia-Aguilar, J.; Patil, S.; Kim, J. K.; Yuval, J. B.; Thompson, H.; Verheij, F.; Lee, M.; Saltz, L. B.; on behalf of the OPRA Consortium
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Pembrolizumab monotherapy for patients with advanced MSI-H colorectal cancer: Longer-term follow-up of the phase II, KEYNOTE-164 study
    Meeting Abstract

    Diaz, L. A.; Le, D. T.; Kim, T. W.; Van Cutsem, E.; Geva, R.; Jaeger, D.; Hara, H.; Burge, M. E.; O'Neil, B. H.; Kavan, P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Pilot program of remote monitoring for high-risk patients on antineoplastic treatment
    Meeting Abstract

    Daly, R. M.; Kuperman, G.; Zervoudakis, A.; Ro, A.; Roy, A.; Baldwin, A.; Salvaggio, R.; Holland, J. C.; Chow, K.; Lauria, T.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • PET-directed chemoradiation (CRT) with induction FOLFOX compared to induction carboplatin/paclitaxel (CP) in patients with locally advanced esophageal adenocarcinoma (EA)
    Meeting Abstract

    Carr, R.; Hsu, M.; Tan, K. S.; Bains, M. S.; Bott, M.; Ilson, D. H.; Isbell, J. M.; Janjigian, Y. Y.; Maron, S. B.; Park, B.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • CX-2009, a CD166-directed probody drug conjugate (PDC): Results from the first-in-human study in patients (Pts) with advanced cancer including breast cancer (BC)
    Meeting Abstract

    Boni, V.; Burris, H. A. 3rd; Liu, J. F.; Spira, A. I.; Arkenau, H. T.; Fidler, M. J.; Rosen, L. S.; Sweis, R. F.; Uboha, N. V.; Sanborn, R. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • The impact of poly ADP ribose polymerase (PARP) inhibitors on clonal hematopoiesis
    Meeting Abstract

    Bolton, K. L.; Moukarzel, L. A.; Ptashkin, R.; Gao, T.; Patel, M.; Caltabellotta, N.; Braunstein, L. Z.; Aghajanian, C.; Hyman, D. M.; Berger, M. F.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save